TP53 and cancer: The Genomics Evidence Neoplasia Information Exchange (GENIE) project by the American Association for Cancer Research (AACR) reports TP53 mutations in 32.8% of cancers, primarily lung adenocarcinoma, breast invasive ductal carcinoma and colon adenocarcinoma (Figure 1) [1].